BioSpace News Archive

Tricida, Inc. announced that it is an executive sponsor of the National Kidney Foundation’s newest public awareness campaign which focuses on the 33 percent of American adults at risk for developing dangerous, life-threatening kidney disease.

Myst Therapeutics (Myst), a preclinical stage biotechnology company focused on developing selected TIL-based autologous T cell therapy products for cancer, announced the appointment of five leading experts in the areas of immunotherapy, tumor infiltrating lymphocytes, gene therapy, and oncology diagnostics to its Scientific Advisory Board.

MIM Software Inc., a leading global provider of medical imaging software, announced today it has received CE Mark approval for its Molecular Radiotherapy product, MIM SurePlan™ MRT.

TFF Pharmaceuticals, Inc. announced that the Company has engaged J.S. Cole & Associates to serve as exclusive financial advisor for the Company’s partnering efforts in Japan.

Aldevron, a global leader in the custom development and manufacture of plasmid DNA, proteins, mRNA and antibodies for the biotech industry, has hired Vijay Surapaneni as its Vice President of Biomanufacturing Operations.

IsoPlexis, the leader in functional cellular proteomics, today announced the upcoming launch of two new additions to its application family, with the fully automated CodePlex Secretome solution for a faster hands-off approach to obtaining highly multiplexed bulk cytokine data and the Single-Cell Innate & Myeloid solution, which uniquely reveals functional sources of immune suppression from rare subsets of innate and myeloid cells.

The Alliance for Aging Research (Alliance) and the National Foundation for Infectious Diseases (NFID) are urging businesses, schools, and federal and state governments to work together to mitigate community spread of COVID-19 and help protect older adults and those with pre-existing medical conditions (such as high blood pressure, heart disease, lung disease, cancer, and/or diabetes),

OxThera AB, a privately-held biopharmaceutical company dedicated to improving the lives of people with Primary Hyperoxaluria (PH), announces the publication of a case report in Pediatric Nephrology.

Biocom, the association representing the California life science industry, concluded its 2020 Advocacy Fly-In to Washington, D.C., this week, connecting research companies to legislators and regulators for the sixth consecutive year.

Minerva Neurosciences, Inc. (NASDAQ: NERV), a clinical-stage biopharmaceutical company focused on the development of innovative therapies to treat unmet medical needs of central nervous system (CNS) disorders, wishes to address a sharp reduction of its share price and subsequent brief trading halt of its shares occurred this morning.